But is the bill he advocated before the Senate Homeland Security and Governmental Affairs Committee really needed? Is it a solution in search of a problem? Data from the Food and Drug Administration (FDA) indicate the answers to those questions are no and yes. But McFadyen, whose Isaac Foundation is based in Ontario and works in Canada and the United States, is no fan of Right to Try. “The cruel reality with Right to Try legislation is that it will not grant patients the immediate access to treatments they desperately need,” he said.

Source: Washington Post September 23, 2016 11:03 UTC